Materials and Methods
Family Studies. Five RFLPs were used to obtain the a chain haplotypes : Bgl II with a Hind III/Eco RI fragment of the Y14 probe (3' Ca region probe) ; Msp I and Taq I, both with a PvuII/Pvu II fragment of Y14 (Ca region probe); Taq I with an Eco RI/Ava I fragment of Y14 (Va region probe) ; Msp I and Pvu II both with the VR5 Va region probe (3) . Six RFLPs were used to obtain the /3 chain haplotypes : Bgl II with a C(3 probe derived from YT35 ; Hind III and Barn HI with a murine C5V probe ; Bam HI with a V/3 probe derived from YT35 ; Taq I and Pvu II both with the V097 probe (7) (8) (9) . The ti chain haplotypes were obtained with Pvu II and a C-y probe as described (5) . The ti chain haplotypes in family S have been published elsewhere (5) .
Cloning Strategy. The OT cDNA library was prepared by modification of the method of Gubler and Hoffman (10) . Poly(A)' RNA from OT leukemia cells was isolated by the guanidinium/CsCl method and passaged over an oligo(dT) cellulose column . First-strand cDNA synthesis was carried out with avian myeloblastosis virus (AMV) reverse transcriptase on 800 ng poly(A)' RNA. Second-strand synthesis was carried out with RNase H and Escherichia coli DNA polymerase I . Blunt ends were prepared with T4 DNA polymerase . Internal Eco RI sites were protected by Eco RI methylase . Kinased Eco RI linkers (New England Biolabs, Beverly, MA) were then ligated onto the cDNA, and the resulting product was digested with Eco RI to produce Eco RI cohesive ends. The cDNA was separated from free linkers by passage over a Sephadex G-50 column and then directly ligated to Eco RI cut, dephosphorylated Xgt10 vector at a molar ratio of 1 :2 . The ligation products were packaged in vitro by standard techniques using E. coli C600 hfl strain as a bacterial host . The OT cDNA library contained 3 .4 x 105 plaque-forming units and was screened with a probe consisting of a 140-bp Pvu II-Bgl II fragment derived from the constant region of a human TCR /3 chain cDNA clone (Jurkat 2) provided by Dr. T Mak (Hospital for Sick Children, Toronto, Ontario, Canada) . Positive plaques from the OT cDNA library were subcloned into Eco RI-digested, phosphatase-treated pIBI 31 vector (International Biotechnologies, Inc ., New Haven, CT) . The purified plasmid was prepared according to Holms and Quigley (11) with modifications . The sequencing reaction was carried out by the dideoxy chain termination method of Sanger et al . (12) , using both T3 and T7 universal primers (Stratagene, Inc., La Jolla, CA) and a DNA sequencing kit (Pharmacia/LKB Biotechnology, Inc., Piscataway, NJ) .
Polymerase Chain Reaction (PCR). Peripheral blood T cells from a normal OT145 +/+ individual were stimulated with OT145 mAb (1 :20 dilution of supernatant) and 10% IL-2 was added twice a week over 2 wk as described (13) . The resultant cell line consisted of >95% OT145' T cells as analyzed by immunofluorescence . RNA was isolated from 5 x 10' cells (yield 30 ug) and first-strand cDNA synthesis was accomplished by adding the C region primer (II) to 10 AM, dNTPs to 1 mM, sodium pyrophosphate to 4 mM, RNAsin 12 U, reverse transcriptase 50 U (Pharmacia Fine Chemicals) in a final reaction volume of 0.02 ml Tris/HCl 50 mM, MgC12 10 mM at pH8 .3 . The reaction was incubated at 43'C for 30 min . Onefourth of this reaction was then used for the PCR reaction with dNTPs (200 AM each), primers I and II at 1 PM each, Taq polymerase 2 .5 U, in a 0 .1-ml reaction volume with 50 mM KCI, 10 mM Tris HCl, pH 8.3, 1 .5 MgC12, 0 .01% (wt/vol) gelatin . The amplified material obtained after 30 cycles of automated PCR hybridized strongly with a VS6.7 probe (Ph79) but not with a V/38 .1 probe by Southern blotting, suggesting that the majority of the amplified material contained V06 gene segments . In other experiments, RNA isolated from 5 x 10' fresh unselected T cells from two OT145 -/-individuals was used as template for first strand cDNA synthesis and PCR amplification of V(36 genes as described above. Similar PCR reactions were also performed with 100 ng germline DNA from an OT145 -/-individual as template and with DNA eluted from the 12-kb band of an agarose gel loaded with Barn HI-digested germline DNA from an OT145 -/-individual and using primers III and IV. PCR products were cloned into the polylinker of a sequencing vector (pIBI31) using restriction enzyme sites added to the 5' ends of the primers used for the PCR as previously described (14) . The primer sequences were : I : 5' CGGAATTCAGGTGTGATCCAATTTC 3' (sense), II : 5' CGGTCGACCTCGGGTGGGAAC 3' (antisense), III : 5' GCGAATTCACC-AGGCTCCTCTTCT 3' (sense), IV. 5' CTGAATTCACAGAGATACACGGCC 3' (antisense) . Southern Blotting .
DNA was isolated from EBVtransformed cell lines from each individual by standard methods (5). 10 j ug DNA was digested with Bam HI or other restriction enzymes and loaded on a 0.8% agarose gel. The blot was hybridized with a 32P-labeled probe corresponding to the 5' 108 nucleotides of the OT-1 clone (Eco RI-Bst XI fragment). After hybridization, the blot was washed twice in 0.1 x SSC, 0.1% SDS at 65°C for 30 min.
Results and Discussion
Initially we performed family studies with several RFLPs of the a, /3, and y chain TCR genes. Haplotypes for these genes could be assigned as previously described (3, 5, 7) and summarized in Fig. 1 . TCR gene haplotypes were compared with HLA haplotypes, obtained by routine serologic typing of the family members and to the OT145-defined phenotype. In family A, only the /3 chain haplotypes correlate with OT145 phenotypes. For instance, the maternal (3 chain "D" haplotype matches with the "-" allele . This is consistent with an OT145 determinant encoded by a (3 chain gene. In family S, four siblings are HLA identical (Sl, S2, S3, S6); yet all three phenotypes defined by OT145 are represented among these individuals, suggesting that HLA type does not influence expression of the OT145 TCR in this family. In murine systems, MHC-encoded products, probably in association with certain autoantigens, may determine TCR V gene usage by causing clonal deletion of T cells expressing a TCR with the autoreactive V gene product. Thus for example, IE+ mouse strains have clonally deleted V017a expressing T cells (15, 16) . The variations in the percentages of OT145+ cells are apparently due to a different mechanism.
To determine which gene encodes the OT145 polymorphic determinant, a cDNA library was constructed from the OT leukemia cells that had served as the immunogen to produce the mAb (6). The library was screened with a /3 chain probe containing C region sequences. A positive clone (OT1) was selected for further study. It contained 252 nucleotides, of which 81 were in the C region, 65 in the D-j region, and 106 in the V region (Fig. 2) . Using OT-1 as a probe, another clone, OT-2 (196 nucleotides), was obtained, which contained only V region sequences, partially overlapping with OT-1 (Fig. 2) . From these sequences, it is apparent that the OT leukemic T cell has a functional rearrangement of V06.7, D/31.1, and jfl.3 and uses the Col gene for its TCR (3 chain. The V06.7 sequences of OT-1 and OT-2 are identical to LI ET AL .
FIGURE 1 .
Results of RFLP typing of two families are summarized and compared with the OT145 defined phenotypes and HLA haplotypes obtained by routine serologic typing. By convention, "a" and "b" denote the paternal, and "c" and "d" the maternal haplotypes . The capitalized haplotypes indicate matching with the OT145 defined "= allele. Individuals with <0 .5% OT145* T cells are typed as -/-, those with up to 3 .0% OT145* T cells as +/-, and those with over 3 .0% OT145* as +/+ (6) . Nine different V gene sequences have been classified as members of the V06 gene subfamily (19) . Some of these sequences differ by only a few nucleotides and could be allelic products of the same gene . To determine which products of these genes are recognized by OT145, OT145`cells were expanded from fresh T cells by adding the mAb with IL-2 to the cultures (13) . After 3 wk, a cell line was obtained containing 95% OT145 T cells as assayed by immunofluorescence . Cytoplasmic RNA was isolated and a first strand cDNA copy was synthesized with reverse transcriptase and then amplified using the PCR. The primers used for the PCR (primers I and II, Fig. 2 ) represent a downstream C region sequence and an upstream V06 sequence that is common to all known V06 genes. Thus it was expected that any V06 genes transcribed in this cell line would be amplified. Seven clones that were positive by hybridization with a V06 probe were isolated . Five of these clones have been sequenced; four have Vf36 .7 sequences (Fig. 2) , and one has a V06.3 sequence ( Fig.  2 ; data not shown) . OT1, PCRclone 1, and UAS2, all derived from OT145 * T cells, contain different D and J regions (Fig . 2) , suggesting that these regions do not encode the OT145 determinant. Thus the combined data suggest that V06.7 is the predominant (although possibly not the only) gene encoding the OT145 determinant.
To further confirm these results, Southern blots of genomic DNA from individuals typed with the OT145 antibody were performed. The CT-1 clone was digested with Bst XI, which cuts this clone in two fragments at the VD junction . The resultant 108-bp V region probe hybridizes to the downstream portion of VQ6.7 genes, and crosshybridizes only minimally with other V(36 genes under high stringency conditions . Several restriction enzymes (Pvu II, Hind III, and Bam HI) revealed polymorphic sites in the vicinity of the V06 .7 gene using this probe. Barn HI, which has a site within the Va6.7 gene (Fig . 2) was chosen for further study. The CT-1-derived V region probe hybridizes predominantly to sequences downstream of this Barn HI site. From individuals typed as +/+ with the OT145 mAb a 4-kb band was consistently obtained, while -/-individuals had a 12-kb band and heterozygous individuals had both bands (Fig . 3) . This analysis was extended to 36 unrelated individuals with similar results (Table I) . Including the members of family S, 42 individuals were screened by Southern blotting with only two individuals in which the RFLP analysis did not match the phenotype obtained with OT145. One such case is sibling 1 in family S where the antibody typing suggested a +/+ genotype, although one value of 3 .0% OT145 + T cells was borderline (Fig. 1) . The Bam HI RFLP, however, typed this individual as heterozygous (4-and 12-kb bands) . TCR /3 chain haplotypes matched the OT145 phenotypes in all but sibling 1 in this family. Such cases could be explained by variations in the percentages of peripheral blood OT145+ T cells due to extraneous influences such as an ongoing immune response . Fig. 3 also demonstrates a second allelic system represented by 4.7-kb and 5 .8-kb bands. Presumably these represent two alleles of another V06 gene that is closely related to V/36 .7 and crosshybridizes under the conditions used . This allelic system represents a fortuitous control since it is not related to the OT145-defined phenotypes (Table 1) . Homozygotes for the 5 .8-kb band are most frequent, followed by heterozygotes (4 .7-and 5.8-kb bands), and only two individuals were found to be homozygotes for the 4.7-kb band. The distribution of these bands is similar among OT145 +/+ and -/-individuals. In contrast the 12-/4-kb Bam HI RFLP matched closely with the OT145 phenotype (Table I) . These data are also consistent with results demonstrating that RFLP-defined alleles of different genes within a TCR haplotype, such as the a chain locus, are not necessarily concordant in population studies (3, 7) .
Southern blots of DNA digested with Bam HI as well as other enzymes showed equal numbers of bands in OT145 +/+ and -/-individuals. Thus a deletion of the V06.7 gene cannot explain the negative staining with OT145. A mutation resulting in a nonexpressed pseudogene, as described in the mouse (20) , remained a possibility. Therefore the Va6.7 gene was amplified by PCR directly from the germline DNA ofan OT145 -/-individual. The primers used (Fig. 2) represent a 3' region of the V06.7 gene (primer IV) and a 5' region in the leader sequence (primer III). Three independent clones were sequenced and revealed identical nucleotide sequences (GL-PA in Fig. 2 ). We termed this sequence "V06 .7b," in contrast to the original sequence, now termed "V06 .7 a" In V06 .7b, a G to A substitution results in abolition of the internal Barn HI restriction enzyme site (Fig. 2) , which is the most probable explanation for the Barn HI 4-/12-kb RFLP shown in Fig. 3 . In +/+ individuals, probes 5' to this site hybridize to an 8-or a 12.5-kb fragment (data not shown) . Together, the 4-and 8-kb fragments represent the 12-kb band of the "-" allele . The Barn HI site defining the 5' margin of the 12-and 8-kb fragments appears itself to be polymorphic. To confirm this interpretation, the 12-kb band (derived from a"-/-" individual) was excised from an agarose gel and the eluted DNA was used as a template for PCR with primers I and IV. The resultant clone had a sequence identical to V06.7b.
To determine whether V06.7b is a functional gene from which mRNA is transcribed, cytoplasmic RNA was isolated from freshly prepared T cells of a"-/--" individual . cDNA was synthesized with reverse transcriptase and PCR amplification was performed with primers I and II to amplify any transcribed V/06 genes. 10 independent clones were sequenced: five had V06.1 sequences, two had V#6.7b sequences, and one each had Va6.2, V(36 .3, and V06.4 sequences. Thus, in this individual V06.7b represented the second most common V06 gene transcribed. The two V06.7b cDNA sequences and the Va6.7b germline sequence (GL-PA, Fig. 2 ) demonstrate no mutation that might result in premature chain termination. In view of the frequency of V06.7b cDNA clones, V06.7b appears to be capable of producing a functional message.
Two nucleotide differences between V06 .7a and V06.7b result in nonconservative amino acid substitutions while the third is located in the intron (Fig. 2) . In the V region encoded by V06.7b residue 38 is changed from a serine to an asparagine and residue 72 is changed from a glycine to a glutamic acid. These residues both represent putative framework residues with high residue variability and high exposure to solvent (21, 22) . This is consistent with the fact that both sites contain charged amino acids in the V06.7b allele, which are unlikely to be buried residues . Position 38 is thought to be located at the margin of a (3-pleated sheet and facing the a chain V domain (22) . Position 72, however, represents the hairpin bend between 0 strands E and D and is probably located close to or at the antigen/MHC binding site (22) . Therefore, substitution of a glutamic acid for a glycine at this site may influence Ag/MHC binding. Whether binding of the OT145 mAb is dependent on position 38, position 72, or both is not evident from our data. However, the epitope recognized by the mAb represents a true allotype of a TCR V region . OT145 is one of only four similar mAbs to different human TCR V regions that we have studied. If one-fourth of such antibodies to TCR V region determinants detect polymorphic determinants, allelic polymorphism of TCR V genes may be a frequent phenomenon . In support of this, evidence for polymorphic Vol products has also been obtained (23) .
MHC-encoded molecules exhibit polymorphisms with numerous alleles. In comparison, the description of two alleles of V06.7 may seem modest . However, a high frequency of genetic recombination has been observed in TCR gene complexes (3).
In addition, our data do not exclude further allelic products ofV06 .7 . Microsatellite regions, such as the (GT)n repeat found in the V#6 .7 intron, have been found to be associated with abundant polymorphism, 4-11 different alleles in one study (24, 25) . These interesting (GT)n repeats are identical to zDNA forming sequences (26, 27) , may be associated with hot spots for recombination (28) (29) (30) , or may participate in gene regulation (31, 32) . The Vf6.7b (GL-PA) sequence has a deletion of 12 nucleotides from this region: i.e., (gt)15 instead of the (gt)21 observed in the V06.7a sequence of UA-S2 (Fig. 2) . This is consistent with observations on the polymorphic nature of these (gt)n repeat sequences (24, 25) .
In view of the absence of somatic mutation in the TCR V genes, TCR V gene allelic products may play a role in increasing the repertoire for the species and for heterozygous individuals . In addition, the finding ofTCR V region polymorphisms has two important predicted consequences . First, there should be immune responses under control of TCR V genes, an example of which has already been described (33) . Second, disease associations with TCR V genes would be expected (34) , possibly due to differences in key residues in the TCR antigen/MHC binding site.
Summary
Polymorphisms ofhuman TCR gene products have been suggested by the description of a mAb, OT145, that identifies a subset of TCRs in some individuals but not in others (6) . Here we demonstrate that this mAb detects a TCR allotype of the V06 .7 gene. Two allelic products of this V gene differ by two nonconservative amino acid substitutions . The mAb OT145 appears to react with V06.7a gene products ("+" allele), but not with V06 .7b gene products allele) . This represents the first direct demonstration that TCR V gene allotypes exist and provides a possible explanation for immune responses under the control of TCR V genes and for disease associations with TCR V genes.
We thank Drs . Tak Mak, Dennis Y. Loh, and Jeffrey P Tillinghast for providing probes .
Received for publication 16 August 1989 and in revisedform 15 September 1989. 
